CANNARA BIOTECH INC (LOVE.CA) Stock Price & Overview

TSX-V:LOVE • CA13765U2002

Current stock price

1.82 CAD
-0.02 (-1.09%)
Last:

The current stock price of LOVE.CA is 1.82 CAD. Today LOVE.CA is down by -1.09%. In the past month the price increased by 2.25%. In the past year, price increased by 30%.

LOVE.CA Key Statistics

52-Week Range1.08 - 2.07
Current LOVE.CA stock price positioned within its 52-week range.
1-Month Range1.73 - 2.05
Current LOVE.CA stock price positioned within its 1-month range.
Market Cap
174.32M
P/E
14.00
Fwd P/E
9.01
EPS (TTM)
0.13
Dividend Yield
N/A

LOVE.CA Stock Performance

Today
-1.09%
1 Week
+2.25%
1 Month
+2.25%
3 Months
-5.21%
Longer-term
6 Months +5.81%
1 Year +30.00%
2 Years +133.33%
3 Years +124.69%
5 Years +21.33%
10 Years N/A

LOVE.CA Stock Chart

CANNARA BIOTECH INC / LOVE Daily stock chart

LOVE.CA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to LOVE.CA. When comparing the yearly performance of all stocks, LOVE.CA turns out to be only a medium performer in the overall market: it outperformed 53.15% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

LOVE.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA. LOVE.CA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LOVE.CA Earnings

On April 14, 2026 LOVE.CA reported an EPS of 0.02 and a revenue of 27.18M.

Next Earnings DateN/A
Last Earnings DateApr 14, 2026
PeriodQ2 / 2026
EPS ReportedCA$0.02
Revenue Reported27.179M
EPS Surprise %
Revenue Surprise %

LOVE.CA Forecast & Estimates

5 analysts have analysed LOVE.CA and the average price target is 3.57 CAD. This implies a price increase of 96.15% is expected in the next year compared to the current price of 1.82.

For the next year, analysts expect an EPS growth of 60% and a revenue growth 22.42% for LOVE.CA


Analysts
Analysts80
Price Target3.57 (96.15%)
EPS Next Y60%
Revenue Next Year22.42%

LOVE.CA Groups

Sector & Classification

Index Membership

LOVE.CA Financial Highlights

Over the last trailing twelve months LOVE.CA reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 76.5% compared to the year before.


Income Statements
Revenue(TTM)112.36M
Net Income(TTM)11.81M
Industry RankSector Rank
PM (TTM) 10.51%
ROA 6.79%
ROE 10.62%
Debt/Equity 0.29
Chartmill High Growth Momentum
EPS Q2Q%-57.14%
Sales Q2Q%20.11%
EPS 1Y (TTM)76.5%
Revenue 1Y (TTM)28.06%

LOVE.CA Ownership

Ownership
Inst OwnersN/A
Shares95.78M
Float44.63M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About LOVE.CA

Company Profile

LOVE logo image Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia and currently employs 452 full-time employees. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.

Company Info

IPO: 2019-01-14

CANNARA BIOTECH INC

Suite 2050 - 1055, West Georgia Street

Vancouver BRITISH COLUMBIA V6E 3P3 CA

Employees: 13

LOVE Company Website

LOVE Investor Relations

Phone: 15149139136.0

CANNARA BIOTECH INC / LOVE.CA FAQ

What does LOVE do?

Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia and currently employs 452 full-time employees. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.


What is the stock price of CANNARA BIOTECH INC today?

The current stock price of LOVE.CA is 1.82 CAD. The price decreased by -1.09% in the last trading session.


Does CANNARA BIOTECH INC pay dividends?

LOVE.CA does not pay a dividend.


What is the ChartMill rating of CANNARA BIOTECH INC stock?

LOVE.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is CANNARA BIOTECH INC worth?

CANNARA BIOTECH INC (LOVE.CA) has a market capitalization of 174.32M CAD. This makes LOVE.CA a Micro Cap stock.


Who owns CANNARA BIOTECH INC?

You can find the ownership structure of CANNARA BIOTECH INC (LOVE.CA) on the Ownership tab.